Images of liposarcoma using technetium-99m bleomycin and technetium (V)-99m DMSA.
The effectiveness of Tc-99m bleomycin (BLM) and Tc(V)-99m DMSA are compared with that of Ga-67 citrate, which is currently the most widely used agent. In four patients with lipomatous tumors, the clinical significance of tumor imaging with each of these three agents is discussed and compared. Results indicate that both Tc-99m BLM and Tc(V)-99m DMSA are superior in detecting the extension or localization of liposarcomas.
D000328:Adult; D001761:Bleomycin / Q000031:analogs & derivatives; D005260:Female; D005710:Gallium Radioisotopes; D006801:Humans; D008080:Liposarcoma / Q000000981:diagnostic imaging*; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds; D015609:Organotechnetium Compounds; D011877:Radionuclide Imaging; D012983:Soft Tissue Neoplasms / Q000000981:diagnostic imaging*; D004113:Succimer; D013438:Sulfhydryl Compounds; D013667:Technetium; D019783:Technetium Tc 99m Dimercaptosuccinic Acid; D013848:Thigh
D005710:Gallium Radioisotopes; D009942:Organometallic Compounds; D015609:Organotechnetium Compounds; D013438:Sulfhydryl Compounds; C051567:technetium Tc 99m bleomycin; D001761:Bleomycin; D019783:Technetium Tc 99m Dimercaptosuccinic Acid; D013667:Technetium; D004113:Succimer